INMD
NASDAQ
Health Care
$15.47
USD
-$0.13 (-0.80%)
At close: Jul 17, 2026, 4:00 PM EDT
Market Cap:
$896.70M
Volume:
609.9K
Previous Close
$15.60
Day Range
$15.39 - $15.67
52 Week Range
$12.72 - $16.74
Average Volume (10 Days)
740.0K
P/E Ratio (TTM)
10.28
Dividend Yield
—
InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. The company is headquartered in Yokneam, Northern (Hazafon) and currently employs 660 full-time employees. The company went IPO on 2019-08-08. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The firm have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
CEO
Mr. Moshe Mizrahy
Headquaters
Yokneam, Northern (HaZafon), IL
Founded
2019
Employees
660